Investment in Instrumentation

At Lancaster Labs, we continually invest in new instrumentation to help control costs and improve TAT. Most recently, we've: “Increased our mass spectrometery services and now offer LTQ-Orbitrap and MALDI-TOF to our ESI-TOF, LC/MS/MS, LC/MS, ICP/MS and GC/MS capabilities.” Lancaster Labs is investing in fast LCs or ultra performance LCs for use in amino acid analysis, peptide mapping and method validation and development. The initial instruments purchased are equipped with ultraviolet (UV) detectors, but future plans include the addition of fast LC with tandem mass spectrometer detection (LC/MS/MS). We've formed a strategic partnership with Smiths Detection to provide IONSCAN LS Ion Mobility Spectrometry (IMS) System technology, which can be used to verify the efficacy of cleaning protocols for pharmaceutical manufacturing. The accuracy, precision, linearity and detection limits produced by IMS methods make it an ideal choice for cleaning validation work.